130 related articles for article (PubMed ID: 38349435)
1. Severe ulcerative colitis induced by COVID-19 vaccination.
Taida T; Kato J; Ishikawa K; Akizue N; Ohta Y; Okimoto K; Saito K; Matsusaka K; Matsumura T; Kato N
Clin J Gastroenterol; 2024 Jun; 17(3):447-450. PubMed ID: 38349435
[TBL] [Abstract][Full Text] [Related]
2. [A case of severe inflammatory bowel disease triggered by vaccination with SARS-CoV-2 mRNA].
Takahashi Y; Shimodaira Y; Yoshida T; Tajika M; Takahashi S; Watanabe K; Fukuda S; Koizumi S; Matsuhashi T; Iijima K
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(4):325-329. PubMed ID: 37032096
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
[TBL] [Abstract][Full Text] [Related]
5. An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature.
Shimada T; Takada J; Baba A; Iwashita M; Hayashi T; Maeda T; Shimizu M
Intern Med; 2024 Mar; 63(6):809-814. PubMed ID: 38171875
[TBL] [Abstract][Full Text] [Related]
6. Case report of new-onset ulcerative colitis after MVC-COVI1901 vaccine injection for SARS-CoV-2.
Kuo HL; Lin TY; Leong PY
Int J Rheum Dis; 2023 Aug; 26(8):1594-1598. PubMed ID: 36876751
[TBL] [Abstract][Full Text] [Related]
7. MORPHOLOGICAL FEATURES OF CELLULAR INFILTRATION IN THE MUCOSA OF LARGE INTESTINE IN ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME.
Dyadyk OO; Snisarevskyi PP; Snisarevska TP
Wiad Lek; 2021; 74(1):57-63. PubMed ID: 33851588
[TBL] [Abstract][Full Text] [Related]
8. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan.
Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394
[TBL] [Abstract][Full Text] [Related]
9. Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination.
Suzuki K; Aizawa M; Tamazawa K; Ueda K; Wada J; Nakajima Y; Shibukawa G; Ikeda S; Tsunoda S; Togashi K
Intern Med; 2024 Mar; 63(5):665-669. PubMed ID: 38171870
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
Alhalabi M; Eddin KA; Ali F; Abbas A
Medicine (Baltimore); 2022 Jan; 101(4):e28722. PubMed ID: 35089243
[TBL] [Abstract][Full Text] [Related]
11. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
[TBL] [Abstract][Full Text] [Related]
12. Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
Macedo Silva V; Lima Capela T; Freitas M; Cúrdia Gonçalves T; Boal Carvalho P; Dias de Castro F; João Moreira M; Cotter J
Inflamm Bowel Dis; 2023 Feb; 29(2):268-273. PubMed ID: 36099059
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
Stercel V; Lóczi L; Kadenczki O; Nemes É; Nagy B; Hodossy-Takács R; Szabó AÁ; Fagyas M; Kappelmayer J; Szabó T; Bagoly Z
Front Immunol; 2023; 14():1257072. PubMed ID: 37965328
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type.
Jørgensen KK; Høivik ML; Chopra A; Benth JŠ; Ricanek P; Moum PB; Jyssum I; Bolstad N; Warren DJ; Vaage PJT; Munthe PLA; Lundin PKEA; Anisdahl K; Syversen SW; Goll GL; Lund-Johansen F; Medhus AW; Jahnsen PJ
Scand J Gastroenterol; 2023; 58(8):874-882. PubMed ID: 36788656
[TBL] [Abstract][Full Text] [Related]
15. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
Sebastian S; Walker GJ; Kennedy NA; Conley TE; Patel KV; Subramanian S; Kent AJ; Segal JP; Brookes MJ; Bhala N; Gonzalez HA; Hicks LC; Mehta SJ; Lamb CA;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):271-281. PubMed ID: 33545083
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Alexander JL; Liu Z; Muñoz Sandoval D; Reynolds C; Ibraheim H; Anandabaskaran S; Saifuddin A; Castro Seoane R; Anand N; Nice R; Bewshea C; D'Mello A; Constable L; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HRT; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Goodhand JR; Hart AL; Lees CW; Boyton RJ; Kennedy NA; Ahmad T; Powell N;
Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1005-1015. PubMed ID: 36088954
[TBL] [Abstract][Full Text] [Related]
17. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
[TBL] [Abstract][Full Text] [Related]
18. BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign.
Ben-Tov A; Banon T; Chodick G; Kariv R; Assa A; Gazit S;
Gastroenterology; 2021 Nov; 161(5):1715-1717.e1. PubMed ID: 34224740
[No Abstract] [Full Text] [Related]
19. Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.
Yoshida Y; Fujioka S; Moriyama T; Umeno J; Kawasaki K; Fuyuno Y; Matsuno Y; Ihara Y; Torisu T; Kitazono T
Intern Med; 2023 Dec; 62(24):3579-3584. PubMed ID: 37779068
[TBL] [Abstract][Full Text] [Related]
20. Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Hartman DS; Tracey DE; Lemos BR; Erlich EC; Burton RE; Keane DM; Patel R; Kim S; Bhol KC; Harris MS; Fox BS
J Crohns Colitis; 2016 Jun; 10(6):641-9. PubMed ID: 26802087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
